Untitled Document
New York Press Release Distribution
Home Page
Submit Press Release
EPR Nationwide Sites
PR Agencies in New York
Browse By Industries
Search Press Releases
About EPR
Help Pages
Contact Us
Disclaimer
Privacy Policy
TOS
 
 
 
(NY) Accounting
(NY) Advertising
(NY) Aerospace
(NY) Agriculture
(NY) Apparel & Fashion
(NY) Automotive
(NY) Biotech
(NY) Chemicals
(NY) Computers
(NY) Construction
(NY) Consumer Services
(NY) Defense
(NY) Education
(NY) Electronics
(NY) Energy
(NY) Entertainment
(NY) Environment
(NY) Financial
(NY) Food & Beverage
(NY) Government
(NY) Healthcare
(NY) Human Resources
(NY) Industrial
(NY) International Trade
(NY) Internet & Online
(NY) Law
(NY) Management
(NY) Marketing
(NY) Media
(NY) Non Profit
(NY) Pharmaceuticals
(NY) Real Estate
(NY) Retail
(NY) Semiconductors
(NY) Small Business
(NY) Software
(NY) Telecom
(NY) Transportation / Logistics
(NY) Travel
 
 

EPR Archived News

Archived News 2010
~ December
~ November
~ October

~ September
~ August
~ July

~ June
~ May
~ April

~ March
~ February

~ January

Archived News 2009
~ December
~ November
~ October
~ September
~ August
~ July

~ June
~ May
~ April
~ March
~ February

~ January

Archived News 2008
~ December
~ November
~ October
~ September
~ August
~ July

~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2007
~ December
~ November
~ October
~ September
~ August

~ July

~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2006
~ December
~ November
~ October
~ September
~ August
~ July

~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2005
~ December
~ November
~ October
~ September
~ August
~ July
~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2004
~ December
~ November
~ October
~ September
~ August
~ July

 

 

 

 

 

Sleep with Rozerem medication

Released on = November 27, 2006, 2:48 am

Press Release Author = olivia andrews

Industry = Pharmaceuticals

Press Release Summary = Rozerem with the active ingredient of Ramelteon has been found working effectively to treat insomnia amongst adults.

Press Release Body = Rozerem that has been eventually approved by the FDA has shown great results upon the people suffering from insomnia. Before this medicine was approved, other sleeping pills used to have narcotic effects whereby gradually it was reduced with sleeping pills such as Ambien, Lunesta, and Sonata.

Rozerem is found to be the first and only medication prescription for use of insomnia in adults. It is prescribed for the treatment of insomnia with symptoms of difficulty in sleep onset. Rozerem can be prescribed for long-term use because the medication does not shows any evidence of abuse or dependence according to sources.

Rozerem has been found different from other sleep drugs and it targets specific switches of the parts of the brain regulating sleep and thereby flipping these switches called melatonin receptors- Rozerem take the brakes of the natural drives of the body.

"In people who sleep normally, the pineal gland in the brain responds to darkness by producing a hormone called melatonin," Mini says. "This natural melatonin dampens the alerting signal so the sleep load overrides [the waking drive] and allows a person to fall asleep."

Unlike melatonin, which has widespread effects throughout the body, Rozerem sends two specific melatonin-like signals to the brains sleep center. This reduces the alerting signal at the time a person wants to go to sleep.

Rozerem should be taken within 30 minutes before going to bed. It should not be taken with or immediately after a high-fat meal. Engaging in hazardous activities that require concentration (such as operating motor vehicle or heavy machinery) after taking Rozerem should be avoided.

The most common side effects seen with Rozerem were somnolence, dizziness, and fatigue. Rozerem should not be used in people with severe liver abnormalities.

So would not over-the-counter melatonin supplements work as well as Rozerem? No, Mini says. Rozerem has a more potent effect on the sleep center of the brain than melatonin supplements. And unlike the supplement, Rozerem has been tested in well-designed studies.

"If you look at the melatonin data, and the recent NIH consensus panel statement, it says that there is little evidence to support the use of melatonin for the treatment of insomnia," Mini says. "And even at that, the dose needed for sleep promotion is unclear. Strict clinical trials of melatonin have not been done. It is an unregulated supplement."

Please visit our website http://www.benzer11.com/rozerem.html to know more about rozerem medicine and other approved prescriptions.


Web Site = http://www.benzer11.com

Contact Details = Binghamton, NY 13902
(607) 722-1734
webmaster@benzer11.com

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •  

     

     

    Untitled Document

     

    Submit Press Release (Free)Submit Press Release

     

    Press Release ForumPress Release Forum

     

    Press Release BlogPress Release Blog

     

     

     

     

     

    Untitled Document

    About | Submit Press Release | Help | Search | Links | Nationwide / EPR Network

    © 2004-2010 NewYork-Press-Release.com. Part of EPR-Network.com. All Rights Reserved. All trade marks and names are owned by their respective owners
    Link to Us / Privacy / Disclaimer / Feedback -- Questions, Suggestions, Comments at E-mail: info@EPR-Network.com
    EPR disclaims any content found in press releases -- full disclaimer can be found here

    Contextually linked in LinkedWords

     

     
    New York Press Release Distribution